Vertex executives had previously cautioned that the rollout of Casgevy, their groundbreaking curative treatment for sickle cell disease,…
The American Society of Hematology (ASH) meeting is in full swing, and Day 2 brought some exciting news.…
Fulcrum Therapeutics recently announced promising results from a study on their experimental pill for sickle cell disease. The…
The event hosted by Scientific American at Morehouse School of Medicine in Atlanta, Georgia was a significant gathering…
The landscape of treatment for patients with sickle cell disease and beta-thalassemia is undergoing a significant transformation. Breakthroughs…
The Centers for Medicare and Medicaid Services recently announced a new program aimed at improving patient access to…
In a striking revelation, New York Attorney General Leticia James was made aware of a conspiracy to stifle…
A groundbreaking gene therapy treatment has successfully cured a 21-year-old man in New York of sickle cell anemia,…
Coercive Care: The Story of Pat Wells You're reading Part 6 of Coercive Care, a yearlong examination of…
SAN DIEGO — The recent withdrawal of Pfizer's sickle cell drug Oxybryta has sparked outrage among sickle cell…
The Republican party and President-elect Donald Trump have a long list of changes they want to make to…
You're reading Part 5 of Coercive Care You're reading Part 5 of Coercive Care, a yearlong examination of…
Sign in to your account